Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis
出版年份 2019 全文链接
标题
Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis
作者
关键词
Preclinical Alzheimer’s disease, Systematic review, Biomarkers, National Institute on Aging–Alzheimer’s Association criteria, Prevalence
出版物
Alzheimers Research & Therapy
Volume 11, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-01-16
DOI
10.1186/s13195-018-0459-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cortical microstructural changes along the Alzheimer's disease continuum
- (2018) Victor Montal et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years
- (2018) Marilyn Albert et al. BRAIN
- Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer’s Disease Pathogenesis
- (2018) Pierre-François Meyer et al. JOURNAL OF ALZHEIMERS DISEASE
- The Emergence of a New Conceptual Framework for Alzheimer’s Disease
- (2018) Bruno Dubois JOURNAL OF ALZHEIMERS DISEASE
- Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study
- (2018) Bruno Dubois et al. LANCET NEUROLOGY
- Age-accelerated cognitive decline in asymptomatic adults with CSF β-amyloid
- (2018) Lindsay R. Clark et al. NEUROLOGY
- Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia
- (2018) Yujing Zhao et al. JAMA Neurology
- Amyloid-β Related Memory Decline is not Associated with Subjective or Informant Rated Cognitive Impairment in Healthy Adults
- (2018) Simone Hollands et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment
- (2017) Steffen Wolfsgruber et al. JOURNAL OF ALZHEIMERS DISEASE
- Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: neuroimaging evidence for protection and compensation
- (2017) Eider M. Arenaza-Urquijo et al. NEUROBIOLOGY OF AGING
- Differential effects of blood insulin and HbA1c on cerebral amyloid burden and neurodegeneration in nondiabetic cognitively normal older adults
- (2017) Min Soo Byun et al. NEUROBIOLOGY OF AGING
- Whole Brain Voxel-Wise Analysis of Cerebral Retention of Beta-Amyloid in Cognitively Normal Older Adults Using 18F-Florbetaben
- (2017) Yoo Hyun Um et al. Psychiatry Investigation
- Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease
- (2017) Philip S. Insel et al. Frontiers in Neuroscience
- Clinically Different Stages of Alzheimer's Disease Associated by Amyloid Deposition with [11C]-PIB PET Imaging
- (2017) Shizuo Hatashita et al. JOURNAL OF ALZHEIMERS DISEASE
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
- (2016) Bruno Dubois et al. Alzheimers & Dementia
- Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease
- (2016) Rachel F. Buckley et al. Alzheimers & Dementia
- In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum
- (2016) Hanna Cho et al. ANNALS OF NEUROLOGY
- Association between Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer’s Disease
- (2016) Monika Mandecka et al. JOURNAL OF ALZHEIMERS DISEASE
- Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study
- (2016) Clifford R Jack et al. LANCET NEUROLOGY
- Local and distributed PiB accumulation associated with development of preclinical Alzheimer's disease
- (2016) Matthew R. Brier et al. NEUROBIOLOGY OF AGING
- Multimorbidity and neuroimaging biomarkers among cognitively normal persons
- (2016) Maria Vassilaki et al. NEUROLOGY
- Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change
- (2016) Anja Soldan et al. JAMA Neurology
- APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern
- (2015) Shannon L. Risacher et al. Alzheimers & Dementia
- Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
- (2015) Stephanie J. B. Vos et al. BRAIN
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease
- (2015) F. L. Besson et al. JOURNAL OF NEUROSCIENCE
- Brain Amyloid Deposition Is Associated With Lower Instrumental Activities of Daily Living Abilities in Older Adults. Results From the MAPT Study
- (2015) Matthieu Lilamand et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly
- (2015) Rebecca E. Amariglio et al. NEUROLOGY
- Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
- (2015) Sebastian Palmqvist et al. NEUROLOGY
- Tracking Early Decline in Cognitive Function in Older Individuals at Risk for Alzheimer Disease Dementia
- (2015) Rebecca E. Amariglio et al. JAMA Neurology
- The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia
- (2015) Brian A. Gordon et al. NeuroImage-Clinical
- Alzheimer's disease progression model based on integrated biomarkers and clinical measures
- (2014) Yue Qiu et al. ACTA PHARMACOLOGICA SINICA
- Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis
- (2014) A. J. Mitchell et al. ACTA PSYCHIATRICA SCANDINAVICA
- An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease
- (2014) Jessica B. Langbaum et al. Alzheimers & Dementia
- A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
- (2014) Frank Jessen et al. Alzheimers & Dementia
- Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
- (2014) Niklas Mattsson et al. BRAIN
- Regional amyloid burden and intrinsic connectivity networks in cognitively normal elderly subjects
- (2014) Hyun Kook Lim et al. BRAIN
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
- (2013) Keith A. Johnson et al. Alzheimers & Dementia
- Is Verbal Episodic Memory in Elderly with Amyloid Deposits Preserved Through Altered Neuronal Function?
- (2013) Rik Ossenkoppele et al. CEREBRAL CORTEX
- Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
- (2013) Stephanie JB Vos et al. LANCET NEUROLOGY
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Aβ-independent processes—rethinking preclinical AD
- (2013) Gaël Chételat Nature Reviews Neurology
- Preclinical AD predicts decline in memory and executive functions in subjective complaints
- (2013) A. C. van Harten et al. NEUROLOGY
- Executive Function Changes before Memory in Preclinical Alzheimer’s Pathology: A Prospective, Cross-Sectional, Case Control Study
- (2013) Michael G. Harrington et al. PLoS One
- Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review
- (2013) Dorene M Rentz et al. Alzheimers Research & Therapy
- Selective Worsening of Brain Injury Biomarker Abnormalities in Cognitively Normal Elderly Persons With β-Amyloidosis
- (2013) David S. Knopman et al. JAMA Neurology
- Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints
- (2012) Argonde C. van Harten et al. Alzheimers & Dementia
- Amyloid deposition, hypometabolism, and longitudinal cognitive decline
- (2012) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement
- (2012) Damian Hoy et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
- (2012) D. S. Knopman et al. NEUROLOGY
- Age and diagnostic performance of Alzheimer disease CSF biomarkers
- (2012) N. Mattsson et al. NEUROLOGY
- -Amyloid burden in healthy aging: Regional distribution and cognitive consequences
- (2012) K. M. Rodrigue et al. NEUROLOGY
- Subjective cognitive complaints and amyloid burden in cognitively normal older individuals
- (2012) Rebecca E. Amariglio et al. NEUROPSYCHOLOGIA
- Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment
- (2012) Liyong Wu et al. PLoS One
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Pre-MCI and MCI: Neuropsychological, Clinical, and Imaging Features and Progression Rates
- (2011) Ranjan Duara et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Longitudinal neuroimaging correlates of subjective memory impairment: 4-year prospective community study
- (2011) Robert Stewart et al. BRITISH JOURNAL OF PSYCHIATRY
- Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
- (2011) Henryk Barthel et al. LANCET NEUROLOGY
- Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
- (2011) Kerryn E. Pike et al. NEUROPSYCHOLOGIA
- Prediction of Dementia by Subjective Memory ImpairmentEffects of Severity and Temporal Association With Cognitive ImpairmentDementia and Subjective Memory Impairment
- (2010) Frank Jessen ARCHIVES OF GENERAL PSYCHIATRY
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- Are subjective cognitive complaints a risk factor for dementia?
- (2010) Roberto Gallassi et al. NEUROLOGICAL SCIENCES
- Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
- (2009) Pieter Jelle Visser et al. LANCET NEUROLOGY
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- White matter lesion severity is associated with reduced cognitive performances in patients with normal CSF Aβ42 levels
- (2008) V. Stenset et al. ACTA NEUROLOGICA SCANDINAVICA
- The pre–mild cognitive impairment, subjective cognitive impairment stage of Alzheimer’s disease
- (2008) Barry Reisberg et al. Alzheimers & Dementia
- Subjective Memory Impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria
- (2008) Khaled Abdulrab et al. EUROPEAN PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search